105 chiorean poster

1
Table 3: Association of CTE variables with Surgical Pathology Mantel-Hanszel chi-square association analysis Table 4: Logistic regression analysis of CTE – Pathology associations Table 2: Accuracy of CTE Compared with Surgical Pathology *Inf = inflammation; FS = fibrostenosis Table 1: Demographic information on n=44 patients included Data presented as median (range) Correlation of CT Enteroclysis with Surgical Pathology in Patients with Crohn’s Disease Michael V. Chiorean, MD, Kumar Sandrasegaran, MD, Dean T Maglinte, MD, Romil Saxena, MD, Attila Nakeeb, MD, Cynthia Calley, MS Indiana University Medical School, Indianapolis, IN A. Pathology Inflammation Score (mean + SE) 0 0.5 1 1.5 2 2.5 3 3.5 1 2 3 CTE Inflammation Score B. Pathology FS Score (mean + SE) 0 0.5 1 1.5 2 0 1 2 CTE Fibrostenosis Score Age 35 (21-79) Male 39% Disease duration (years) 8 (1-37) Indications for surgery Bowel obstruction Perforating disease Refractory non-obstructive disease 21 13 15 Background: The response to medical therapy in patients with Crohn’s disease (CD) depends on the underlying inflammatory or fibrostenotic pathology. Standard diagnostic methods cannot distinguish between these two phenotypes. CT enteroclysis (CTE) has superior small bowel resolution. The ability of CTE to differentiate pathological lesions in CD is unknown. Aims: To determine the accuracy of CTE compared to pathology in patients who underwent surgery for CD To assess the correlation of specific CTE findings with the pathological diagnosis. Michael Chiorean, MD – Principal Investigator Division of Gastroenterology and Hepatology Indiana University Medical Center 550 N University Blvd., UH 4100 Indianapolis, IN 46202 (317) 274-6474 (317) 274-0975 fax [email protected] CTE findings from 44 adult patients who underwent surgery for CD were compared to the gold-standard surgical pathology The accuracy of CTE was determined by using a composite inflammatory and fibrostenotic score. The correlation between CTE variables and surgical pathology was assessed using Mantel-Haenszel chi-square, Spearman correlation and logistic regression analyses. r = 0.6, p<0.0001 r = 0.7, p <0.0001 Sensitivity (%) Specificity (%) Accuracy (%) Inflammation if CTE Inf* score 2 94 79 87.2 Fibrosis if CTE FS* score 1 95 83 89.4 Path Inf score Path FS score OR p-value OR p-value Mural stratification 13 1.86 0.29 1.4 0.67 Wall enhancement 25 2.24 0.09 0.95 0.93 Comb sign 46 5.52 0.0003 1.11 0.82 Adenopathy 47 2.69 0.02 1.07 0.88 Stenosis 47 0.77 0.54 5.87 0.006 Pre-stenotic dilation 40 0.71 0.38 2.0 0.22 CTE variable n 0.44 0.38 40 Pre-stenotic dilation 0.07 0.49 38 Stenosis severity 0.76 0.7 29 Stenosis length 0.001 0.55 47 Stenosis (yes/no) 0.88 0.016 47 Adenopathy 0.82 <0.0001 47 Comb sign 0.93 0.086 25 Wall enhancement 0.21 0.046 45 Wall thickness 0.68 0.29 13 Mural stratification 0.18 0.042 12 Mucosal enhancement Path Fibrostenosis (p-value) Path Inflammation (p-value) n Fig 3: Spearman rank correlation of CTE with Surgical Pathology: A: Inflammation B: Fibrostenosis Conclusions: CTE can reliably differentiate between inflammatory and fibrostenotic lesions in patients with small bowel CD Specific CTE variables correlate with each CD phenotype Further prospective studies evaluating CTE in CD are warranted. References: 1. Maglinte DD, Bender GN, Heitkamp DE et al. Multidetector helical CT enteroclysis. Radiol Clin North Am. ’03;41(2):249-62. 2. Gourtsoyiannis N, Makko E. Imaging of primary small intestinal tumours by enteroclysis and CT with pathological correlation. Eur. Radiol. ’97;7:626-42. 3. Boudiaf M, Jaff A, Soyer P, Bouhnik Y, Hamzi L, et al. Small bowel diseases: prospective evaluation of multi-detector row helical CT enteroclysis in 107 consecutive patients. Radiology ’04;233:338-4. 4. Gore RM, Balthazar EJ, Ghahremani GG et al. CT features of ulcerative colitis and Crohn’s disease. AJR ’96;167:3-15. 5. Mako EK, Mester AR, Tarjan A et al. Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel Crohn’s disease. Eur J Radiol. ’00; 35:168-75. 6. Wold PB, Fletcher JG, Johnson CD et al. Assessment of small bowel Crohn Disease: noninvasive peroral CT enterography compared with other imaging methods and endoscopy – feasibility study. Radiology ’03;229:275-81. Contact Information Fig 2: Example of a predominantly inflammatory lesion: A) CTE; B,C) Pathology specimen Inflammatory score: 3; Fibrostenotic score: 1 a) wall thickening; b) mucosal enhancement; c) comb sign; d) transmural fissure a c b d A B C Methods: Results: Supported by a BMRP grant # IBD -0179R to MVC Fibro-stenosis Fibrosis Muscular hyperplasia Strictures Fibro-stenosis Thick non-enhancing wall Luminal stenosis Prestenotic dilation Inflammation (macro or microscopic) Erosions or ulcerations Mucosal inflammation Cryptitis PMN and mononuclear infiltrates Lymphadenopathy Inflammation Mucosal enhancement Mural stratification Wall thickness (mm) Wall enhancement Comb sign Adenopathy Pathology variables CTE Variables The final score was calculated as the sum of individual variables for each lesion resected (0-3 for inflammation; 0-2 for fibrosis) Fig 1: Example of a predominantly fibrostenotic lesion: A) CTE; B) Pathology specimen Severe luminal narrowing (arrowhead) with minimal mucosal enhancement (arrow) Inflammatory score: 1; Fibrostenotic score: 3 B a c A

Upload: just-mahasiswa

Post on 20-Jan-2016

16 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: 105 Chiorean Poster

Table 3: Association of CTE variables with Surgical Pathology

Mantel-Hanszel chi-square association analysis

Table 4: Logistic regression analysis of CTE – Pathology associations

Table 2: Accuracy of CTE Compared with Surgical Pathology

*Inf = inflammation; FS = fibrostenosis

Table 1: Demographic information on n=44 patients included

Data presented as median (range)

Correlation of CT Enteroclysis with Surgical Pathology in Patients with Crohn’s DiseaseMichael V. Chiorean, MD, Kumar Sandrasegaran, MD, Dean T Maglinte, MD, Romil Saxena, MD, Attila Nakeeb, MD, Cynthia Calley, MS

Indiana University Medical School, Indianapolis, IN

A. Pathology Inflammation Score (mean + SE)

00.5

11.5

22.5

33.5

1 2 3CTE Inflammation Score

B. Pathology FS Score (mean + SE)

0

0.5

1

1.5

2

0 1 2CTE Fibrostenosis Score

Age 35 (21-79)

Male 39%

Disease duration (years) 8 (1-37)

Indications for surgeryBowel obstructionPerforating diseaseRefractory non-obstructive disease

211315

Background:• The response to medical therapy in patients with Crohn’s disease (CD) depends on the underlying inflammatory or fibrostenotic pathology. • Standard diagnostic methods cannot distinguish between these two phenotypes. • CT enteroclysis (CTE) has superior small bowel resolution. • The ability of CTE to differentiate pathological lesions in CDis unknown.

Aims: • To determine the accuracy of CTE compared to pathology in patients who underwent surgery for CD • To assess the correlation of specific CTE findings with the pathological diagnosis.

Michael Chiorean, MD – Principal Investigator

Division of Gastroenterology and Hepatology

Indiana University Medical Center

550 N University Blvd., UH 4100

Indianapolis, IN 46202

(317) 274-6474

(317) 274-0975 fax

[email protected]

• CTE findings from 44 adult patients who underwent surgery for CD were compared to the gold-standard surgical pathology

• The accuracy of CTE was determined by using a composite inflammatory and fibrostenotic score.

• The correlation between CTE variables and surgical pathology was assessed using Mantel-Haenszel chi-square, Spearman correlation and logistic regression analyses.

r = 0.6, p<0.0001r = 0.7, p <0.0001

Sensitivity (%) Specificity (%) Accuracy (%)

Inflammation if CTE Inf* score ≥ 2 94 79 87.2

Fibrosis if CTE FS* score ≥ 1 95 83 89.4

Path Inf score Path FS score

OR p-value OR p-value

Mural stratification 13 1.86 0.29 1.4 0.67

Wall enhancement 25 2.24 0.09 0.95 0.93

Comb sign 46 5.52 0.0003 1.11 0.82

Adenopathy 47 2.69 0.02 1.07 0.88

Stenosis 47 0.77 0.54 5.87 0.006

Pre-stenotic dilation 40 0.71 0.38 2.0 0.22

CTE variable n

0.440.3840Pre-stenotic dilation0.070.4938Stenosis severity0.760.729Stenosis length

0.0010.5547Stenosis (yes/no)0.880.01647Adenopathy0.82<0.000147Comb sign0.930.08625Wall enhancement0.210.04645Wall thickness0.680.2913Mural stratification0.180.04212Mucosal enhancement

Path Fibrostenosis(p-value)

Path Inflammation(p-value)n

Fig 3: Spearman rank correlation of CTE with Surgical Pathology: A: Inflammation B: Fibrostenosis

Conclusions:• CTE can reliably differentiate between inflammatory and fibrostenotic lesions in patients with small bowel CD • Specific CTE variables correlate with each CD phenotype• Further prospective studies evaluating CTE in CD are warranted.

References:1. Maglinte DD, Bender GN, Heitkamp DE et al. Multidetector helical CT enteroclysis. Radiol Clin North Am.

’03;41(2):249-62.2. Gourtsoyiannis N, Makko E. Imaging of primary small intestinal tumours by enteroclysis and CT with pathological

correlation. Eur. Radiol. ’97;7:626-42.3. Boudiaf M, Jaff A, Soyer P, Bouhnik Y, Hamzi L, et al. Small bowel diseases: prospective evaluation of multi-detector

row helical CT enteroclysis in 107 consecutive patients. Radiology ’04;233:338-4.4. Gore RM, Balthazar EJ, Ghahremani GG et al. CT features of ulcerative colitis and Crohn’s disease. AJR ’96;167:3-15.5. Mako EK, Mester AR, Tarjan A et al. Enteroclysis and spiral CT examination in diagnosis and evaluation of small bowel

Crohn’s disease. Eur J Radiol. ’00; 35:168-75.6. Wold PB, Fletcher JG, Johnson CD et al. Assessment of small bowel Crohn Disease: noninvasive peroral CT

enterography compared with other imaging methods and endoscopy – feasibility study. Radiology ’03;229:275-81.

Contact Information

Fig 2: Example of a predominantly inflammatory lesion: A) CTE; B,C) Pathology specimenInflammatory score: 3; Fibrostenotic score: 1

a) wall thickening; b) mucosal enhancement; c) comb sign; d) transmural fissure

a

c

b d

A B

C

Methods: Results:

Supported by a BMRP grant # IBD -0179R to MVC

Fibro-stenosisFibrosisMuscular hyperplasiaStrictures

Fibro-stenosisThick non-enhancing wallLuminal stenosisPrestenotic dilation

Inflammation (macro or microscopic)Erosions or ulcerationsMucosal inflammationCryptitisPMN and mononuclear infiltratesLymphadenopathy

InflammationMucosal enhancementMural stratificationWall thickness (mm)Wall enhancementComb signAdenopathy

Pathology variablesCTE Variables

The final score was calculated as the sum of individual variables for each lesion resected (0-3 for inflammation; 0-2 for fibrosis)

Fig 1: Example of a predominantly fibrostenotic lesion: A) CTE; B) Pathology specimenSevere luminal narrowing (arrowhead) with minimal mucosal enhancement (arrow)

Inflammatory score: 1; Fibrostenotic score: 3

B

a

c

A